Ephedrine enhances HIV-1 reactivation from latency through elevating tumor necrosis factor receptor II (TNFRII) expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ephedrine enhances HIV-1 reactivation from latency through elevating tumor necrosis factor receptor II (TNFRII) expression

Published:2019-09 Issue:9 Volume:5 Page:e02490
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Panaampon Jutatip,Kudo Eriko,Kariya Ryusho,Okada Seiji

Funder

Research Program on HIV/AIDS

Japan Agency for Medical Research and Development

Grants-in-Aid for Science Research

Ministry of Education, Science, Sports, and Culture of Japan

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference35 articles.

1. Cellular reservoirs of HIV-1 and their role in viral persistence;Alexaki;Curr. HIV Res.,2008

2. Eradicating HIV-1 infection: seeking to clear a persistent pathogen;Archin;Nat. Rev. Microbiol.,2014

3. An integrated overview of HIV-1 latency;Ruelas;Cell,2013

4. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy;Chun;Nat. Med.,2000

5. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression;Davey;Proc. Natl. Acad. Sci. U. S. A.,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanisms;International Immunopharmacology;2024-09

2. The use of Ephedra herbs in the treatment of COVID-19;AVICENNA J PHYTOMEDI;2023

3. Effect of Chinese herbal medicine therapy on risks of all-cause mortality, infections, parasites, and circulatory-related mortality in HIV/AIDS patients with neurological diseases;Frontiers in Pharmacology;2023-03-03

4. Efficacy and mechanism of the anti-CD38 monoclonal antibody Daratumumab against primary effusion lymphoma;Cancer Immunology, Immunotherapy;2021-09-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3